Details for Patent: 7,858,594
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,858,594 protect, and when does it expire?
Patent 7,858,594 protects TYZEKA and is included in two NDAs.
This patent has eleven patent family members in seven countries.
Summary for Patent: 7,858,594
Title: | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
Abstract: | Physical forms of beta-L-2'-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2'-deoxythymidine can be used in the manufacture of other forms of beta-L-2'-deoxythymidine, or in pharmaceutical compositions. Particularly preferred uses are in the treatment of hepatitis B. |
Inventor(s): | Jonaitis; David (West Lafayette, IN), Storer; Richard (Kent, GB) |
Assignee: | Novartis Pharma AG (Basel, CH) |
Application Number: | 12/505,839 |
Patent Claim Types: see list of patent claims | Compound; Formulation; Composition; Dosage form; Use; |
Drugs Protected by US Patent 7,858,594
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TYZEKA | telbivudine | SOLUTION;ORAL | 022154-001 | Apr 28, 2009 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | Y | Y | TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS | See Plans and Pricing | ||
Novartis | TYZEKA | telbivudine | TABLET;ORAL | 022011-001 | Oct 25, 2006 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | TREATMENT OF CHRONIC HEPATITIS B IN ADULT PATIENTS | See Plans and Pricing | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,858,594
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003265396 | See Plans and Pricing | |||
China | 100376593 | See Plans and Pricing | |||
China | 1714098 | See Plans and Pricing | |||
European Patent Office | 1534727 | See Plans and Pricing | |||
European Patent Office | 2607370 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |